Women using oral contraceptives should use a non-oral or backup method of contraception for 4 weeks after starting tirzepatide and for 4 weeks after each dose escalation
Clinical benefit has now been reported in single-agent Phase II trials currently underway in patients with advanced platinum-resistant non-small-cell lung cancer, platinum-resistant ovarian-cancer and 5-FU, leucovorin and irinotecan-resistant colon cancer (Kavanagh et al ., 2002
Choosing a time that fits naturally into a patients weekly routine helps improve adherence, avoid missed doses, and achieve long-term treatment results
J Lipid Res 44(2):388398 Caimen F, Wolters J, Smit E, Schrooders Y, Kleinjans J, van den Beucken T (2020) Valproic acid promotes mitochondrial dysfunction in primary human hepatocytes in vitro, impact of C/EBP-controlled gene expression
The increased risk sounds bigger in percentage terms (37% to 68% higher) than it looks in real numbers: about 7 in 1,000 GLP-1 patients per year got a hair loss diagnosis, versus 4 to 5 in 1,000 on the comparison drugs
Adv Colloid Interface Sci 209:172184